Long-term outcomes of intrathecal baclofen in ambulatory multiple sclerosis patients: A single-center experience.

Justin R AbbatemarcoAustin GriffinNoble G JonesJennifer HartmanKeith McKeeZhini WangSean J NagelAndre G MachadoFrancois Bethoux

Published in: Multiple sclerosis (Houndmills, Basingstoke, England) (2020)

ITB is effective for ambulatory MS patients without compromising short-term walking speed, although a higher complication rate was observed in this cohort.

Keyphrases

multiple sclerosis
end stage renal disease
newly diagnosed
ejection fraction
blood pressure
peritoneal dialysis
mass spectrometry
patient reported outcomes